(52.14.97.206)
Users online: 15969     
Ijournet
Email id
 

Journal Of Veterinary Pharmacology And Toxicology
Year : 2023, Volume : 22, Issue : 1
First page : ( 22) Last page : ( 25)
Print ISSN : 0972-8872.

Pharmacokinetics of danofloxacin after intravenous administration in rabbits

Prajapati D. R., Patel H. A.*, Mody S. K., Patel H.B., Modi C. M.

Department of Pharmacology and Toxicology, College of Veterinary Science and Animal Husbandry, Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar - 385 506 (Gujarat, India)

*Corresponding author's e-mail: patelharshad49@gmail.com

Online published on 28 November, 2023.

Abstract

The present study was conducted to investigate the pharmacokinetic properties of danofloxacin in rabbits. Plasma concentrations of danofloxacin were determined by ultra-high performance liquid chromatography (UHPLC). Pharmacokinetic parameters were derived from plasma concentrations and time data using PK Solver 2.0 software. After a single intravenous injection of danofloxacin at 5.0 mg/kg body weight, the elimination rate constant (2) values ranged from 0.14 to 0.18 1/h, with a mean value of 0.16 1/h. The calculated mean value of the corresponding half-life (t1/22) was 4.31 h, with a range from 3.94 to 4.96 h. The mean value for the area under the curve (AUC) of plasma concentration of danofloxacin versus time was 6.09 μg.h/mL, and the mean value for the area under the first moment of plasma concentration (AUMC) was 22.44 1/4g.h2 /mL. The mean residence time (MRT) averaged 3.68 hours. The mean apparent volume of distribution (Vd(area)) and steady-state volume of distribution (Vd(ss)) were 5.12 and 3.03 L/kg, respectively. The mean value of total body clearance (ClB) was 0.82 L/kg/h.

Top

Keywords

Danofloxacin, Intravenous, Pharmacokinetics, Rabbit, UHPLC.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
751,086,850 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.